ClinicalTrials.Veeva

Menu

The Development of a Virtual Reality Program to Improve Attention in Individuals With TBI

Kessler Foundation logo

Kessler Foundation

Status

Unknown

Conditions

TBI (Traumatic Brain Injury)

Treatments

Behavioral: Virtual Reality Executive Function Training (VREFT)

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT03605017
R-820-14

Details and patient eligibility

About

The purpose of this research is to investigate the effectiveness of a technique designed to improve divided attention and set-shifting impairments in persons with a traumatic brain injury (TBI). The study is designed to evaluate how well this technique can help people with TBI increase their attention and ability to function better in everyday life.

Full description

A pilot study will be conducted to evaluate the effectiveness of a technique designed to improve higher level attention (switching between tasks and multi-tasking) for persons with a traumatic brain injury. 32 individuals with TBI will be recruited. Baseline assessment includes neuropsychological evaluation using traditional measures as well as a completion of a number of questionnaires designed to measure everyday attention and everyday functioning. Participants are random assigned to either the experimental or control groups. Experimental and control treatments include two 60 minute sessions, twice per week, for 5 weeks. Follow-up assessment includes a neuropsychological evaluation using traditional measures as well as a completion of a number of questionnaires designed to measure everyday attention and everyday functioning. Protocol efficacy will be determined by improvements between baseline and follow-up on several objective and functional measures of divided attention and set-shifting.

Enrollment

32 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • between the ages of 18-65
  • diagnosis of TBI
  • can read and speak English fluently

Exclusion criteria

  • prior stroke or neurological disease other than TBI
  • unstable or uncontrolled seizures
  • currently taking benzodiazepines

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

32 participants in 2 patient groups

VREFT: Wonderkin Treatment
Experimental group
Description:
Administered by computer
Treatment:
Behavioral: Virtual Reality Executive Function Training (VREFT)
VREFT: Attention Control
Active Comparator group
Description:
Administered by computer
Treatment:
Behavioral: Virtual Reality Executive Function Training (VREFT)

Trial contacts and locations

1

Loading...

Central trial contact

Denise Krch, PhD; Angela Smith, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems